Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Zephyr Pharmatec (pvt) limited

Private pharmaceutical manufacturer · Karachi · Pakistan

Karachi pharmaceutical manufacturer focused on generic medicines, contract manufacturing and quality-controlled production.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date17 Aug 2026Newest effective date among published current price records
Corporate profile evidence3 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Zephyr Pharmatec (Pvt.) Limited
Company type
Private pharmaceutical manufacturer
Address
A-39, S.I.T.E. II, Super Highway, Karachi, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
63%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000403 Zephyr Pharmatec (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000403 85 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx87public portfolio records represented
REG74unique registrations represented
IDX53indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR80current validated price records
G38generic molecules in indexed catalogue
DF10dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage92%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixZephyr Pharmatec (pvt) limitedShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zephyr-pharmatec-pvt-limitedGenerated 23 Sep 2026Anti-infectives53 · 62%Vitamins, minerals & nutrition12 · 14%Respiratory & allergy6 · 7%Cardiovascular4 · 5%Gastrointestinal & hepatology4 · 5%Pain & musculoskeletal2 · 2%Fluids & supportive care1 · 1%Other therapeutic areas3 · 4%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioZephyr Pharmatec (pvt) limitedDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zephyr-pharmatec-pvt-limitedGenerated 23 Sep 202685presentationsTablet37 · 44%Suspension15 · 18%Capsule12 · 14%Syrup8 · 9%Injection4 · 5%Infusion3 · 4%Other forms6 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionZephyr Pharmatec (pvt) limitedCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zephyr-pharmatec-pvt-limitedGenerated 23 Sep 202682comparable productsBelow peer median17 · 21%Near peer median22 · 27%Above peer median43 · 52%Company median price position+5.5%Lowest-price equivalents5Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsZephyr Pharmatec (pvt) limitedCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/zephyr-pharmatec-pvt-limitedGenerated 23 Sep 2026Nabiqasim Industries (Pvt) Ltd.,25 shared66% overlapMacter International Limited23 shared61% overlapBio-Labs(Pvt) Ltd23 shared61% overlapMediate Pharmaceutical Pvt Ltd22 shared58% overlapS.J & G. Fazul Ellahie (pvt) limite…22 shared58% overlapBosch Pharmaceuticals (Pvt) Ltd.21 shared55% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives53 products · 62%
Vitamins, minerals & nutrition12 products · 14%
Respiratory & allergy6 products · 7%
Cardiovascular4 products · 5%
Gastrointestinal & hepatology4 products · 5%
Pain & musculoskeletal2 products · 2%
Fluids & supportive care1 products · 1%
Reproductive & genitourinary1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Vitamins / minerals / hematinics12 products · 14%
Antimalarials11 products · 13%
Macrolide antibacterials9 products · 11%
Fluoroquinolone antibacterials9 products · 11%
Oxazolidinone antibacterials7 products · 8%
Antihistamines6 products · 7%
Antifungals5 products · 6%
Third-generation cephalosporins5 products · 6%
Formulation footprint

Dosage forms

Tablet37 products
Suspension15 products
Capsule12 products
Syrup8 products
Injection4 products
Infusion3 products
Cream2 products
Sachet2 products
Gel1 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CazidLinezolid 7presentations 100 mg/5 mL, 200 mg, 400 mg, 400 mg/200 mL · Suspension, Infusion, Tablet #2 AnacinCiprofloxacin 6presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #3 KlueClarithromycin 5presentations 125 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet #4 WizyCefixime 5presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Tablet, Capsule #5 AdmiraAzithromycin 4presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #6 AspenFexofenadine 3presentations 120 mg, 180 mg, 60 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1721% of comparable products
Near market median22within ±5% of median
Above market median4352% of comparable products
Lowest-price equivalents5ties included
Company median price position +5.5% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Mantan 10 mgIsosorbide dinitrate · Tablet · 100's PKR 0.80/tablet-53.2% vs market median Folic - CP 5 mgFolic acid · Tablet · 1000's PKR 0.38/tablet-53.0% vs market median Mectozel 20 mgMiconazole · Gel · 20gm PKR 5.74/g-32.3% vs market median Irene 500 mg + 25 mgSulfadoxine + Pyrimethamine · Tablet · 10's PKR 6.40/tablet-32.0% vs market median Irene 500 mg + 25 mgSulfadoxine + Pyrimethamine · Tablet · 1's PKR 6.93/tablet-26.4% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 25shared generics Macter International Limited256 products · 93 generics 23shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 23shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 22shared generics S.J & G. Fazul Ellahie (pvt) limited.193 products · 68 generics 22shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 21shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers72Distinct registrations among indexed, published, presentation-validated products only
Verified price observations165
Products with a verified price85
Products with multiple price observations80
Source records with multiple versions85
Latest portfolio source check22 Sep 2026
Latest effective price date17 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

74 unique registration(s) · 53 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Admira Azithromycin 500 mg Capsule 3's 067635 PKR 261.70 PKR 87.23/capsule Near median
Admira Azithromycin 200 mg/5 mL Suspension 15ml 074861 PKR 345.46 PKR 23.03/mL 6% above median
Admira Azithromycin 250 mg Capsule 2x5's 074864 PKR 533.87 PKR 53.39/capsule 8% above median
Admira Azithromycin 500 mg Tablet 6's 086986 PKR 566.44 PKR 94.41/tablet 11% above median
Ajutor Chloroquine 250 mg Tablet 50x10's 105093 PKR 579.26 PKR 1.16/tablet 26% below median
Ajutor Chloroquine 50 mg/5 mL Syrup 60ml 105094 PKR 18.01 PKR 0.30/mL 11% below median
Anacin Ciprofloxacin 250 mg Tablet 1x10's 018781 PKR 367.95 PKR 36.80/tablet 46% above median
Anacin Ciprofloxacin 500 mg Tablet 1x10's 018782 PKR 647.62 PKR 64.76/tablet 51% above median
Anacin Ciprofloxacin 250 mg/5 mL Dry suspension 90ml 070748 PKR 495.48 PKR 5.51/mL 9% above median
Anacin Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 070748 PKR 330.31 PKR 5.51/mL 9% above median
Anacin Ciprofloxacin 125 mg/5 mL Dry suspension 90ml 070749 PKR 287.92 PKR 3.20/mL 9% below median
Anacin Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 070749 PKR 191.95 PKR 3.20/mL 9% below median
Cazid Linezolid 400 mg Tablet 12's 088168 PKR 2,911.99 PKR 242.67/tablet 5% above median
Cazid Linezolid 600 mg Tablet 12's 088169 PKR 5,097.95 PKR 424.83/tablet 8% above median
Cazid Linezolid 100 mg/5 mL Suspension 60ml 088170 PKR 698.07 PKR 11.63/mL 6% above median
Cazid Linezolid 100 mg/5 mL Suspension 120ml 088170 PKR 1,326.35 PKR 11.05/mL Near median
Cazid Linezolid 200 mg IV infusion 100ml 091197 PKR 685.83 PKR 6.86/mL 5% below median
Cazid Linezolid 600 mg IV infusion 300ml 091198 PKR 1,164.79 PKR 3.88/mL Near median
Cazid Linezolid 400 mg/200 mL IV infusion 200ml 104089 PKR 1,046.81 PKR 5.23/mL 25% above median
Cizova Vancomycin 500 mg Lyophilized powder for injection 1's 112791 PKR 1,465.55 PKR 1,465.55/vial/unit 25% above median
Cizova Vancomycin 1 g Lyophilized powder for injection 1's 112792 PKR 2,365.81 PKR 2,365.81/vial/unit 40% above median
Crocus Levofloxacin 250 mg Tablet 10's 050534 PKR 516.28 PKR 51.63/tablet 8% above median
Crocus Levofloxacin 500 mg Tablet 10's 050535 PKR 859.09 PKR 85.91/tablet 9% above median
Dotara Fluconazole 50 mg Capsule 7's 066823 PKR 948.55 PKR 135.51/capsule 10% above median
Dotara Fluconazole 150 mg Capsule 1's 066824 PKR 355.17 PKR 355.17/capsule 35% above median
Evazol Clotrimazole 1 % Cream 10gm 018790 PKR 102.58 PKR 10.26/g 66% above median
Hydramal Hydroxychloroquine 200 mg Tablet 5x10's 105088 PKR 942.13 PKR 18.84/tablet 30% above median
Hydramal Hydroxychloroquine 200 mg Tablet 30's 105088 PKR 565.28 PKR 18.84/tablet 30% above median
Irene Sulfadoxine + Pyrimethamine 500 mg + 25 mg Tablet 2's 018773 PKR 13.86 PKR 6.93/tablet 26% below median
Irene Sulfadoxine + Pyrimethamine 500 mg + 25 mg Tablet 1's 018773 PKR 6.93 PKR 6.93/tablet 26% below median
Irene Sulfadoxine + Pyrimethamine 500 mg + 25 mg Tablet 10's 018773 PKR 63.99 PKR 6.40/tablet 32% below median
Klue Clarithromycin 250 mg Tablet 10's 018775 PKR 764.82 PKR 76.48/tablet 61% above median
Klue Clarithromycin 500 mg Tablet 10's 067404 PKR 918.70 PKR 91.87/tablet 10% above median
Klue Clarithromycin 125 mg/5 mL Suspension 60ml 086744 PKR 444.77 PKR 7.41/mL Near median
Klue Clarithromycin 125 mg/5 mL Suspension 25ml 086744 PKR 185.31 PKR 7.41/mL Near median
Klue Clarithromycin 500 mg Tablet 5's 090816 PKR 401.86 PKR 80.37/tablet Near median
Maloff 20 Artemether + Lumefantrine 20 mg + 120 mg Tablet 16's 055012 PKR 660.84 PKR 41.30/tablet 5% above median
Maloff 30/180 Artemether + Lumefantrine 30 mg + 180 mg Suspension 60ml 086870 PKR 617.94 PKR 10.30/mL Near median
Maloff-DS Artemether + Lumefantrine 40 mg + 240 mg Tablet 8'S 055561 PKR 563.06 PKR 70.38/tablet 10% above median
Maloff-Extra Artemether + Lumefantrine 80 mg + 480 mg Tablet 4's 058401 PKR 469.20 PKR 117.30/tablet 8% above median
Mectozel Miconazole 20 mg Gel 20gm 067405 PKR 114.76 PKR 5.74/g 32% below median
Mectozel Miconazole 20 mg Cream 20gm 067406 PKR 188.43 PKR 9.42/g 62% above median
Melica Metronidazole (Benzoate) 200 mg Suspension 120ml 061148 PKR 129.73 PKR 1.08/mL 19% above median
Tamizep Oseltamivir 75 mg Capsule 10's 105090 PKR 1,125.51 PKR 112.55/capsule 7% below median
Wizy Cefixime 100 mg/5 mL Suspension 30ml 047333 PKR 330.35 PKR 11.01/mL Near median
Wizy Cefixime 200 mg/5 mL Suspension 30ml 047334 PKR 404.29 PKR 13.48/mL Near median
Wizy Cefixime 200 mg Capsule 5's 047335 PKR 351.90 PKR 70.38/capsule 12% above median
Wizy Cefixime 400 mg Capsule 5's 047336 PKR 591.99 PKR 118.40/capsule Near median
Wizy Cefixime 200 mg Tablet 10's 088322 PKR 646.79 PKR 64.68/tablet Near median
Xitocin Moxifloxacin 400 mg Tablet 5's 055563 PKR 994.47 PKR 198.89/tablet 8% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Zephyr Pharmatec (pvt) limited — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/zephyr-pharmatec-pvt-limited/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.